HROWL News and Press, Harrow Health Inc. 8.625% senior notes due 2026 From 02/05/24

2024-02-05 03:26:15 ET Summary Harrow has two outstanding notes on offer that come up for maturity in 2026 and 2027. The 11.875% Senior Notes due 2027 offer a compelling 11.5% yield on cost and trade at a just under 3% premium to their $25 per share liquidation value. Cash and...

2024-01-19 13:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-02 07:09:05 ET Summary The Bloomberg report alleging an investigation into Franchise Group, Inc. (FRG)'s CEO relates to a fraud case against one of his associates from a previous employment, unlikely to impact RILY or FRG. Management is committed to its $1 quarterly distri...

2023-12-13 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-17 14:58:48 ET Summary Strategies for generating passive income include income investing, real estate investment trusts, master limited partnerships, exchange-traded debt, bonds, value-add property, joint ventures/REITs, and peer-to-peer lending. Preferred stocks, REITs, M...

2023-11-15 00:33:34 ET Summary Harrow is a company focused on eye health with a strong distribution platform and CEO ownership. Q3 earnings were below expectations, and guidance was lowered, raising concerns about operational performance. However, the company has lots of oppor...

2023-11-13 21:25:23 ET Harrow, Inc. (HROW) Q3 2023 Earnings Conference Call November 13, 2023 16:45 ET Corporate Participants Jamie Webb - Director-Communications & Investor Relations Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer ...

2023-08-09 22:35:07 ET Harrow Health, Inc. (HROW) Q2 2023 Earnings Conference Call August 09, 2023 04:45 PM ET Company Participants Jamie Webb - Director-Communications & Investor Relations Mark L. Baum - Chief Executive Officer & Chairman-Board of Directors ...

2023-08-01 11:00:00 ET Summary Harrow Health is an eye care pharmaceuticals company. The common stock has been on fire with expectations of rapidly increasing profits. HROW has 2 baby bonds, with one looking particularly interesting given an 11.6% yield to maturity. ...

2023-05-11 21:43:09 ET Harrow Health, Inc. (HROW) Q1 2023 Earnings Conference Call May 11, 2023, 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer Conferenc...